Cryptocurrencies
Biogen Stock Slumps As Medicare Limits Alzheimer’s Drug Coverage To Patients in Clinical Trials
The U.S. Centers for Medicare and Medicaid Services said it will only cover treatment with Aduhelm, Biogen’s Alzheimer’s treatment, if patients are enrolled in a clinical trial. Biogen (BIIB) – Get Biogen Inc. Report shares slumped Read more…